Similarly, Yang et al. (2013) modified gold–iron oxide heteronanostructures with EGFR-specific affibodies post-assembly, incorporating radiolabels for PET, optical, and magnetic resonance imaging (MRI) of EGFR-expressing tumors, resulting in high tumor uptake and multimodal contrast via maleimide chemistry [48]. This evidence concerns the gene EGFR and neoplasm.